Life Molecular Imaging Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
138
- Latest Deal Type
-
M&A
- (Announced)
- Financing Rounds
-
3
Life Molecular Imaging General Information
Description
Developer of novel PET tracers designed for molecular imaging research and development services. The company through its PET tracers helps improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes as well as provide services such as research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities, thereby allowing physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine.
Contact Information
Website
www.life-mi.com(Operating Subsidiary)
Corporate Office
- Tegeler Strasse 6-7
- 13353 Berlin
- Germany
Corporate Office
- Tegeler Strasse 6-7
- 13353 Berlin
- Germany
Life Molecular Imaging Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Life Molecular Imaging Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Life Molecular Imaging Patents
Life Molecular Imaging Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3224301-A1 | A novel kit for radiopharmaceutical preparation of a radiometal labeled chelate-functionalized targeting conjugate | Pending | 29-Jun-2021 | ||
| AU-2022302933-A1 | A novel kit for radiopharmaceutical preparation of a radiometal labeled chelate-functionalized targeting conjugate | Pending | 29-Jun-2021 | ||
| EP-4362989-A2 | A novel kit for radiopharmaceutical preparation of a radiometal labeled chelate-functionalized targeting conjugate | Pending | 29-Jun-2021 | ||
| US-20210041447-A1 | Azacarboline compounds for the detection of tau aggregates | Inactive | 24-Jan-2018 | ||
| EP-3743426-A1 | Azacarboline compounds for the detection of tau aggregates | Inactive | 24-Jan-2018 | G01N33/60 |
Life Molecular Imaging Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Life Molecular Imaging Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Life Molecular Imaging FAQs
-
When was Life Molecular Imaging founded?
Life Molecular Imaging was founded in 2012.
-
Where is Life Molecular Imaging headquartered?
Life Molecular Imaging is headquartered in Berlin, Germany.
-
What is the size of Life Molecular Imaging?
Life Molecular Imaging has 138 total employees.
-
What industry is Life Molecular Imaging in?
Life Molecular Imaging’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Life Molecular Imaging a private or public company?
Life Molecular Imaging is a Private company.
-
What is the current valuation of Life Molecular Imaging?
The current valuation of Life Molecular Imaging is .
-
What is Life Molecular Imaging’s current revenue?
The current revenue for Life Molecular Imaging is .
-
Who are Life Molecular Imaging’s investors?
Bayer and Piramal Group have invested in Life Molecular Imaging.
-
When was Life Molecular Imaging acquired?
Life Molecular Imaging was acquired on 13-Jan-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
